Synthetic Biology: At the Crossroads of Genetic Engineering and Human Therapeutics

Web Desc
MEETING CANCELLED: Synthetic Biology: At the Crossroads of Genetic Engineering and Human Therapeutics
Organizer(s): Jose M. Lora and Timothy K. Lu
Date: March 29 - April 01, 2020
Location: Beaver Run Resort, Breckenridge, CO, USA
Sponsored by Astellas Pharma Inc., BlueRock Therapeutics, Burroughs Wellcome Fund and Editas Medicine
For important information on the coronavirus, please click here
Summary of Meeting:
Synthetic Biology tools and principles have matured tremendously over the last decade and have reached extraordinary levels of sophistication, both in eukaryotic and prokaryotic systems. Synthetic biology as a therapeutic modality is starting to enter multiple clinical studies and has the potential to have a significant impact on medicine across a wide range of diseases (e.g., metabolic, immune-mediated, cancer, and neurologic diseases). This Keystone Symposia conference will delve into the field of synthetic biology with a special emphasis on its applications to medicine. While there are conferences that capture synthetic biology in only a few talks mixed in among other various topics, there is a paucity of conferences focused on synthetic biology as drugs to treat disease. However, due to the rapid pace of fundamental scientific advances along with an expanding number of biotechnology companies and emerging clinical studies with synthetic biology at their core, this conference will be highly relevant for a wide audience of scientists both from academia and industry. In addition, other meetings in this field have a highly technology-driven focus on synthetic biology techniques with relatively little attention given to biological and medical context. Ultimately, this Keystone Symposia conference should inspire researchers from diverse backgrounds to discuss synthetic biology via many new angles.
Meeting has been cancelled. Please call our office if you have questions at 970-262-1230 or 1-800-253-0685.


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Astellas Pharma Inc.BlueRock TherapeuticsEditas Medicine
We gratefully acknowledge additional support for this conference from:
American Society of Gene & Cell Therapy (ASGCT)Burroughs Wellcome Fund
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Grant No. 1R13EB029305-01
Funding for this conference was made possible (in part) by 1R13EB029305-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found